SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-005646
Filing Date
2019-04-19
Accepted
2019-04-18 18:54:58
Documents
4
Period of Report
2019-04-18
Effectiveness Date
2019-04-19

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 521389
2 def14a_001.jpg GRAPHIC 3858
3 proxy_001.jpg GRAPHIC 145912
4 proxy_002.jpg GRAPHIC 100301
  Complete submission text file 0001493152-19-005646.txt   867159
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21617 | Film No.: 19756878
SIC: 2834 Pharmaceutical Preparations